Related Experiment Video
Updated: Jun 14, 2026

Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain
Published on: July 24, 2016
Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis
1Division of Viral Pathogenesis, Department of Neurology, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.
Abstract:
Progressive multifocal leukoencephalopathy (PML) is a rare but often fatal brain disease caused by reactivation of the polyomavirus JC. Knowledge of the characteristics of PML has substantially expanded since the introduction of combination antiretroviral therapy during the HIV epidemic and the development of immune reconstitution inflammatory syndrome (IRIS) in patients with PML. Recently, the monoclonal antibodies natalizumab, efalizumab, and rituximab--used for the treatment of multiple sclerosis, psoriasis, haematological malignancies, Crohn's disease, and rheumatic diseases--have been associated with PML. Additionally, the JC virus can also lead to novel neurological disorders such as JC virus granule cell neuronopathy and JC virus encephalopathy, and might also cause meningitis. The increasingly diverse populations at risk and the recent discovery of the presence of the JC virus in the grey matter invite us to reappraise the pathogenesis of this virus in the CNS.
Insights
Progressive multifocal leukoencephalopathy (PML), a fatal brain disease from JC virus reactivation, is increasingly linked to new therapies. Understanding JC virus pathogenesis is crucial due to diverse at-risk populations and novel neurological disorders.
Area of Science:
- Neuroscience
- Virology
- Immunology
Background:
- Progressive multifocal leukoencephalopathy (PML) is a rare, fatal brain disease caused by JC polyomavirus reactivation.
- PML understanding evolved with HIV treatment and immune reconstitution inflammatory syndrome (IRIS).
- Monoclonal antibodies (natalizumab, efalizumab, rituximab) are newly associated with PML risk.
Purpose of the Study:
- To reappraise JC virus pathogenesis in the central nervous system (CNS).
- To highlight novel JC virus-associated neurological disorders.
- To address the expanding population at risk for PML and related conditions.
Main Methods:
- Review of recent literature on PML, JC virus, and associated therapies.
- Analysis of epidemiological data linking monoclonal antibodies to PML.
- Examination of emerging JC virus-related neurological conditions.
Main Results:
- JC virus reactivation causes PML, with increased incidence linked to certain therapies.
- JC virus is associated with granule cell neuronopathy, encephalopathy, and meningitis.
- JC virus presence in grey matter necessitates a broader understanding of its CNS impact.
Conclusions:
- The spectrum of JC virus-related CNS diseases is expanding.
- Diverse patient populations are now at risk for PML and novel neurological disorders.
- Reappraisal of JC virus pathogenesis is essential given new clinical associations and viral localization.
Related Concept Videos
Encephalitis ll: Pathophysiology
Encephalitis l: Introduction
Cerebral Edema ll: Pathophysiology
Bacterial Meningitis II: Pathophysiology
Cytomegalovirus Disease
Arboviral Encephalitis

